Brief: ViewRay Announces China Nmpa Approval Of Its Mridian® Mri-Guided Radiation Therapy For Cancer Patients
07/09/2022 11:44
Sept 7 (Reuters) - ViewRay Inc VRAY.O :
* VIEWRAY ANNOUNCES CHINA NMPA APPROVAL OF ITS MRIDIAN®
MRI-GUIDED
RADIATION THERAPY FOR CANCER PATIENTS
Source text for Eikon: ID:nPnB1Qj8a
Further company coverage: VRAY.O
(Reporting by Pratik Jain)
((Pratik.Jain@thomsonreuters.com;))
Recent news on Viewray
See all newsBrief: ViewRay Announces Commencement Of Nasdaq Delisting Proceedings Common Stock Expected To Begin Trading On The OTC Markets
Press Digest: Wall Street Journal - July 18
U.S. STOCKS ON THE MOVE-Argenx, ViewRay, Ford
ViewRay hits record low on filing for voluntary Chapter 11 bankruptcy
U.S. STOCKS ON THE MOVE-Activision Blizzard, Tesla, Paramount Global